Pioglitazone/metformin (Actoplus met).
出版信息
Med Lett Drugs Ther. 2006 Jan 30;48(1227):9-11.
PMID:16444136
Abstract
摘要
相似文献
1
Pioglitazone/metformin (Actoplus met).
Med Lett Drugs Ther. 2006 Jan 30;48(1227):9-11.
2
[2-year data of large clinical comparative studies. Type 2 diabetes: lasting metabolic control with pioglitazone].
MMW Fortschr Med. 2004 Jul 22;146(29-30):48-9.
3
Pioglitazone + metformin: new drug. A combination product to avoid.
Prescrire Int. 2007 Aug;16(90):144.
4
Sitagliptin/metformin (Janumet) for type 2 diabetes.
Med Lett Drugs Ther. 2007 Jun 4;49(1262):45-7.
5
A fixed-dose combination of pioglitazone and metformin: A promising alternative in metabolic control.
Curr Med Res Opin. 2006;22 Suppl 2:S39-48. doi: 10.1185/030079906X121002.
6
[Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
MMW Fortschr Med. 2007 Aug 2;149(31-32):52-3.
7
Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
Circulation. 2003 Dec 9;108(23):2941-8. doi: 10.1161/01.CIR.0000103683.99399.7E.
8
Pioglitazone/glimepiride (Duetact) for diabetes.
Med Lett Drugs Ther. 2007 Jan 29;49(1253):9-11.
9
Thiazolidinediones in type 2 diabetes: a cardiology perspective.
Ann Pharmacother. 2008 Oct;42(10):1466-74. doi: 10.1345/aph.1K666. Epub 2008 Sep 2.
10
Pioglitazone and metformin.
Drugs Today (Barc). 2007 Jul;43(7):443-54. doi: 10.1358/dot.2007.43.7.1119722.
Zotero 插件